View More Recent Stories

Sep 17, 2024 06:48AM Mizuho Reiterates Neutral Rating on Charles River Labs (CRL)
Sep 4, 2024 08:06AM Charles River Laboratories (CRL) and Insightec Announce Strategic Collaboration to Advance Therapeutic Development Utilizing Focused Ultrasound in Neuroscience
Aug 13, 2024 06:44AM Charles River Labs (CRL) PT Lowered to $210 at Mizuho
Aug 12, 2024 08:15AM Charles River Labs (CRL) PT Lowered to $203 at TD Cowen
Aug 8, 2024 05:55AM JPMorgan Downgrades Charles River Labs (CRL) to Neutral
Aug 8, 2024 03:05AM Baird Downgrades Charles River Labs (CRL) to Neutral
Aug 7, 2024 07:06AM Charles River Laboratories (CRL) Tops Q2 EPS by 40c; lowers guidance
Jul 30, 2024 08:04AM Charles River Laboratories (CRL) Collaborates with Patient Advocacy Group, FOXG1 Research Foundation to Advance Rare Disease Gene Therapy Development
Jul 24, 2024 08:03AM Charles River Laboratories (CRL) and Autobahn Labs Announce Collaborative Program to Accelerate Academic Drug Discovery
Jul 15, 2024 02:00PM Life Science Tools & Diagnostics stocks: Q2 earnings preview
Jul 10, 2024 07:26AM Charles River Labs (CRL) PT Lowered to $239 at Baird
Jun 28, 2024 07:38AM Argus Downgrades Charles River Labs (CRL) to Hold, 'bearish pattern of lower highs and lower lows'
Jun 28, 2024 03:14AM Barclays Starts Charles River Labs (CRL) at Equalweight
Jun 13, 2024 06:28AM Charles River Labs (CRL) PT Raised to $271 at Baird
View More Recent Stories